Reply To: Traders Market Weekly: Summer, Manufacturing, Jobs and Debt Ceiling

#59095
TradersCom
Keymaster

PTC Therapeutics (PTCT) announces “topline” results from Vatiquinone MOVE-FA registration-directed trial; to continue development and global commercialization of Upstaza as part of a strategic portfolio prioritization; estimated reductions of approx. 15% in residual 2023 OpEx…

PTCT down 21.8%